These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27453094)

  • 1. Exposure of Norwegian toddlers to perfluoroalkyl substances (PFAS): The association with breastfeeding and maternal PFAS concentrations.
    Papadopoulou E; Sabaredzovic A; Namork E; Nygaard UC; Granum B; Haug LS
    Environ Int; 2016 Sep; 94():687-694. PubMed ID: 27453094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M
    Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
    Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
    Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies.
    Papadopoulou E; Haug LS; Sabaredzovic A; Eggesbø M; Longnecker MP
    Environ Res; 2015 Jul; 140():421-9. PubMed ID: 25957838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort.
    Richterová D; Fábelová L; Patayová H; Pulkrabová J; Lanková D; Rausová K; Šovčíková E; Štencl J; Hajšlová J; Trnovec T; Palkovičová Murínová Ľ
    Environ Int; 2018 Dec; 121(Pt 2):1304-1310. PubMed ID: 30420127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal and childhood perfluoroalkyl substances exposures and children's reading skills at ages 5 and 8years.
    Zhang H; Yolton K; Webster GM; Ye X; Calafat AM; Dietrich KN; Xu Y; Xie C; Braun JM; Lanphear BP; Chen A
    Environ Int; 2018 Feb; 111():224-231. PubMed ID: 29241079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort.
    Impinen A; Longnecker MP; Nygaard UC; London SJ; Ferguson KK; Haug LS; Granum B
    Environ Int; 2019 Mar; 124():462-472. PubMed ID: 30684804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.
    Berg V; Nøst TH; Huber S; Rylander C; Hansen S; Veyhe AS; Fuskevåg OM; Odland JØ; Sandanger TM
    Environ Int; 2014 Aug; 69():58-66. PubMed ID: 24815340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.
    Rush EL; Singer AB; Longnecker MP; Haug LS; Sabaredzovic A; Symanski E; Whitworth KW
    Environ Int; 2018 Mar; 112():156-164. PubMed ID: 29274593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
    Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
    J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort.
    Liang H; Wang Z; Miao M; Tian Y; Zhou Y; Wen S; Chen Y; Sun X; Yuan W
    Environ Health; 2020 Nov; 19(1):127. PubMed ID: 33243245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.